NormOxys' Series B - II Round

NormOxys raised a round of funding on May 24, 2010.

NormOxys has discovered and is currently developing a proprietary technology platform that generates a class of small molecule drugs, oxyrens, which enhance the body's ability to deliver oxygen more e…

Articles about NormOxys' Series B - II Round: